May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
Is Intracameral Cefuroxime Better Than Subconjunctival Cefuroxime in Preventing Endophthalmitis?
Author Affiliations & Notes
  • P. Yu-Wai-Man
    Sunderland Eye Infirmary, Sunderland, United Kingdom
  • S. J. Morgan
    Sunderland Eye Infirmary, Sunderland, United Kingdom
  • A. J. Hildreth
    Department of Statistics, University of Sunderland, Sunderland, United Kingdom
  • D. H. Steel
    Sunderland Eye Infirmary, Sunderland, United Kingdom
  • D. Allen
    Sunderland Eye Infirmary, Sunderland, United Kingdom
  • Footnotes
    Commercial Relationships  P. Yu-Wai-Man, None; S.J. Morgan, None; A.J. Hildreth, None; D.H. Steel, None; D. Allen, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2873. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Yu-Wai-Man, S. J. Morgan, A. J. Hildreth, D. H. Steel, D. Allen; Is Intracameral Cefuroxime Better Than Subconjunctival Cefuroxime in Preventing Endophthalmitis?. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2873. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

To compare the efficacy of intracameral cefuroxime versus subconjunctivalcefuroxime in reducing the rate of endophthalmitis followingcataract surgery


A retrospective analysis was performed of all presumed infectiousendophthalmitis (PIE) cases from January 1, 2000 to December31, 2006, at Sunderland Eye Infirmary, a single specialty eyeunit. From January 1, 2000 to November 16, 2003, all patientsreceived a subconjunctival injection of cefuroxime at the endof the procedure. A change of practice occurred on November17, 2003 and all patients were instead given an intracameralinjection of cefuroxime. The rate of PIE between these two groupswas compared using Chi-squared test with Yates correction forcategorical data (Table 1).


36,743 phacoemulsification procedures were included in thisstudy and the average rate of PIE was 0.95 per 1,000 cases from2000 to 2006 (Figure 1). The incidence of endophthalmitis washigher in the group receiving subconjunctival cefuroxime comparedto the intracameral route and this difference was statisticallysignificant with an odds ratio of 3.01 (95% CI 1.37 to 6.63).


Our study is the first to directly compare the efficacy of intracameraland subconjunctival cefuroxime in the prophylaxis of post-operativeendophthalmitis. Although confirmatory studies are needed, ourresults indicate that the intracameral route is a safe alternativeto subconjunctival delivery of cefuroxime and leads to a lowerrate of endophthalmitis.  


Keywords: endophthalmitis • antibiotics/antifungals/antiparasitics • clinical (human) or epidemiologic studies: outcomes/complications 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.